{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:54:48Z","timestamp":1778770488744,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06683-6","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:05:43Z","timestamp":1762923943000},"page":"6275-6284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epstein-barr virus-encoded small RNA incorporated prognostic model enables precision risk stratification and guides treatment decisions in peripheral t-cell lymphoma: a multicenter retrospective cohort"],"prefix":"10.1007","volume":"104","author":[{"given":"Ze-Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Guo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Di","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Miao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Juan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Chu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-E.","family":"LIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"2","key":"6683_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100646","volume":"38","author":"C Amador","year":"2025","unstructured":"Amador C et al (2025) Refining diagnostic subtypes of peripheral T-cell lymphoma using a multiparameter approach. Mod Pathol 38(2):100646. https:\/\/doi.org\/10.1016\/j.modpat.2024.100646","journal-title":"Mod Pathol"},{"issue":"11","key":"6683_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.medj.2024.07.029","volume":"5","author":"SA Atallah-Yunes","year":"2024","unstructured":"Atallah-Yunes SA, Wang Y (2024) Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotype. Med 5(11):1335\u20131337. https:\/\/doi.org\/10.1016\/j.medj.2024.07.029","journal-title":"Med"},{"issue":"2","key":"6683_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.19255","volume":"204","author":"K Bednarska","year":"2024","unstructured":"Bednarska K et al (2024) Epstein\u2013Barr virus-associated lymphomas decoded. Br J Haematol 204(2):415\u2013433. https:\/\/doi.org\/10.1111\/bjh.19255","journal-title":"Br J Haematol"},{"key":"6683_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05702-9","author":"J Chen","year":"2024","unstructured":"Chen J et al (2024) Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-024-05702-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"6683_CR5","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3109\/10428194.2013.861068","volume":"55","author":"Y-P Chen","year":"2014","unstructured":"Chen Y-P et al (2014) Epstein\u2013Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas. Leuk Lymphoma 55(9):2038\u20132047. https:\/\/doi.org\/10.3109\/10428194.2013.861068","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"6683_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41379-019-0392-8","volume":"33","author":"J Cho","year":"2020","unstructured":"Cho J et al (2020) Immune subtyping of extranodal NK\/T-cell lymphoma: a new biomarker and an immune shift during disease progression. Mod Pathol 33(4):603\u2013615. https:\/\/doi.org\/10.1038\/s41379-019-0392-8","journal-title":"Mod Pathol"},{"issue":"1","key":"6683_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins GS et al (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med 13(1):1. https:\/\/doi.org\/10.1186\/s12916-014-0241-z","journal-title":"BMC Med"},{"key":"6683_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01765-w","author":"K-X Du","year":"2024","unstructured":"Du K-X et al (2024) Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms. Cell Commun Signal. https:\/\/doi.org\/10.1186\/s12964-024-01765-w","journal-title":"Cell Commun Signal"},{"key":"6683_CR9","doi-asserted-by":"publisher","unstructured":"Efthimiou O et al. (2024) \u201cDeveloping clinical prediction models: a step-by-step guide,\u201d BMJ, p. e078276. Available at: https:\/\/doi.org\/10.1136\/bmj-2023-078276.","DOI":"10.1136\/bmj-2023-078276"},{"issue":"7","key":"6683_CR10","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103(7):2474\u20132479. https:\/\/doi.org\/10.1182\/blood-2003-09-3080","journal-title":"Blood"},{"key":"6683_CR11","unstructured":"Haverkos, B.M. et al (2017) \u201cFrequency and clinical correlates of elevated plasma Epstein‐Barr virus DNA at diagnosis in peripheral T‐cell lymphomas,\u201d Int. J. Cancer [Preprint]."},{"issue":"15","key":"6683_CR12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB et al (2019) Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133(15):1664\u20131676. https:\/\/doi.org\/10.1182\/blood-2018-09-872549","journal-title":"Blood"},{"key":"6683_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02980-8","author":"L Huang","year":"2025","unstructured":"Huang L et al (2025) Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in China: a multicenter, real-world study. Discover Oncol. https:\/\/doi.org\/10.1007\/s12672-025-02980-8","journal-title":"Discover Oncol"},{"key":"6683_CR14","doi-asserted-by":"publisher","unstructured":"Huh J et al (1999) \u201cDetection of Epstein-Barr virus in Korean peripheral T-cell lymphoma,\u201d American Journal of Hematology, 60(3), pp. 205\u2013214. Available at: https:\/\/doi.org\/10.1002\/(sici)1096-8652(199903)60:3%253C205::aid-ajh7%253E3.0.co;2-j","DOI":"10.1002\/(sici)1096-8652(199903)60:3%253C205::aid-ajh7%253E3.0.co;2-j"},{"key":"6683_CR15","doi-asserted-by":"publisher","unstructured":"International T-Cell Lymphoma Project (2008) \u201cInternational Peripheral T-Cell and Natural Killer\/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes,\u201d J Clin Oncol 26(25) 4124\u20134130. Available at: https:\/\/doi.org\/10.1200\/jco.2008.16.4558","DOI":"10.1200\/jco.2008.16.4558"},{"issue":"18","key":"6683_CR16","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood.2023021787","volume":"144","author":"J Iqbal","year":"2024","unstructured":"Iqbal J, Inghirami G, Chan WC (2024) New insights into the biology of T-cell lymphomas. Blood 144(18):1873\u20131886. https:\/\/doi.org\/10.1182\/blood.2023021787","journal-title":"Blood"},{"key":"6683_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5114\/pjp.2015.53013","volume":"2","author":"S Karaarslan","year":"2015","unstructured":"Karaarslan S et al (2015) Original paper evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization. Pol J Pathol 2:161\u2013169. https:\/\/doi.org\/10.5114\/pjp.2015.53013","journal-title":"Pol J Pathol"},{"issue":"2","key":"6683_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/path.6067","volume":"260","author":"A Kondo","year":"2023","unstructured":"Kondo A et al (2023) Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma. J Pathol 260(2):124\u2013136. https:\/\/doi.org\/10.1002\/path.6067","journal-title":"J Pathol"},{"issue":"4","key":"6683_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaad.2018.08.053","volume":"81","author":"WJ Lee","year":"2019","unstructured":"Lee WJ et al (2019) Cutaneous angioimmunoblastic T-cell lymphoma: epstein-barr virus positivity and its effects on clinicopathologic features. J Am Acad Dermatol 81(4):989\u2013997. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.053","journal-title":"J Am Acad Dermatol"},{"key":"6683_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01904-w","author":"Y Luan","year":"2024","unstructured":"Luan Y et al (2024) Therapeutic challenges in peripheral T-cell lymphoma. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-023-01904-w","journal-title":"Mol Cancer"},{"key":"6683_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46501-5","author":"N Nakamura","year":"2023","unstructured":"Nakamura N et al (2023) Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-46501-5","journal-title":"Sci Rep"},{"key":"6683_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00248-19","author":"H Nakhoul","year":"2019","unstructured":"Nakhoul H et al (2019) High-throughput sequence analysis of peripheral T-cell lymphomas indicates subtype-specific viral gene expression patterns and immune cell microenvironments. mSphere. https:\/\/doi.org\/10.1128\/msphere.00248-19","journal-title":"mSphere"},{"issue":"3","key":"6683_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/ajh.27165","volume":"99","author":"SY Ong","year":"2024","unstructured":"Ong SY, Zain JM (2024) Aggressive T-cell lymphomas: 2024: updates on diagnosis, risk stratification, and management. Am J Hematol 99(3):439\u2013456. https:\/\/doi.org\/10.1002\/ajh.27165","journal-title":"Am J Hematol"},{"key":"6683_CR24","doi-asserted-by":"publisher","unstructured":"Riley, R.D. et al. (2020) \u201cCalculating the sample size required for developing a clinical prediction model,\u201d. BMJ m441. Available at: https:\/\/doi.org\/10.1136\/bmj.m441","DOI":"10.1136\/bmj.m441"},{"issue":"8","key":"6683_CR25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41379-019-0264-2","volume":"32","author":"A Satou","year":"2019","unstructured":"Satou A et al (2019) Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Mod Pathol 32(8):1135\u20131146. https:\/\/doi.org\/10.1038\/s41379-019-0264-2","journal-title":"Mod Pathol"},{"key":"6683_CR26","unstructured":"Sejic, N. et al. (no date) \u201cBCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus\u2013associated T\/NK-cell lymphoma.\u201d"},{"issue":"Supplement 1","key":"6683_CR27","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1182\/blood-2021-149970","volume":"138","author":"Z Shen","year":"2021","unstructured":"Shen Z et al (2021) Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and EBER status in lymphomas: a retrospective multicenter study in Huaihai Lymphoma Working Group. Blood 138(Supplement 1):4570\u20134570. https:\/\/doi.org\/10.1182\/blood-2021-149970","journal-title":"Blood"},{"key":"6683_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0439-6","author":"Y Shi","year":"2017","unstructured":"Shi Y et al (2017) Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-017-0439-6","journal-title":"J Hematol Oncol"},{"issue":"5","key":"6683_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.21147\/j.issn.1000-9604.2023.05.10","volume":"35","author":"Y Shi","year":"2023","unstructured":"Shi Y et al (2023) Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients. Chin J Cancer Res 35(5):536\u2013549. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.05.10","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"6683_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, B\u00fchlmann P (2012) Missforest\u2014non-parametric missing value imputation for mixed-type data. Bioinformatics 28(1):112\u2013118. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597","journal-title":"Bioinformatics"},{"issue":"20","key":"6683_CR31","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"6683_CR32","doi-asserted-by":"publisher","unstructured":"Tang F and Ishwaran H (2017) \u201cRandom Forest Missing Data Algorithms.\u201d arXiv. Available at: https:\/\/doi.org\/10.48550\/arXiv.1701.05305","DOI":"10.48550\/arXiv.1701.05305"},{"key":"6683_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01293-5","author":"E Tse","year":"2022","unstructured":"Tse E et al (2022) How we treat NK\/T-cell lymphomas. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-022-01293-5","journal-title":"J Hematol Oncol"},{"issue":"11","key":"6683_CR34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.v106.11.811.811","volume":"106","author":"JM Vose","year":"2005","unstructured":"Vose JM, The International PTCL Project (2005) International peripheral T-cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood 106(11):811\u2013811. https:\/\/doi.org\/10.1182\/blood.v106.11.811.811","journal-title":"Blood"},{"key":"6683_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835103","author":"J Wang","year":"2022","unstructured":"Wang J et al (2022) Comparison of chemotherapy combined with Chidamide versus chemotherapy in the frontline treatment for peripheral T-cell lymphoma. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.835103","journal-title":"Front Immunol"},{"issue":"16","key":"6683_CR36","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/jco.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P et al (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24(16):2472\u20132479. https:\/\/doi.org\/10.1200\/jco.2005.03.6327","journal-title":"J Clin Oncol"},{"key":"6683_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100126","volume":"10","author":"SE Yoon","year":"2021","unstructured":"Yoon SE et al (2021) Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia. The Lancet Regional Health - Western Pacific 10:100126. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100126","journal-title":"The Lancet Regional Health - Western Pacific"},{"key":"6683_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01199-0","author":"M Zhu","year":"2024","unstructured":"Zhu M et al (2024) Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed\/refractory angioimmunoblastic T-cell lymphoma. Blood Cancer J. https:\/\/doi.org\/10.1038\/s41408-024-01199-0","journal-title":"Blood Cancer J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06683-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06683-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06683-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:18Z","timestamp":1767485718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06683-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6683"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06683-6","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of each participating center and was conducted in accordance with the Declaration of Helsinki. On a voluntary participation basis, each patient had consented to the use of their clinical data and research findings for this study and academic publication. The study protocol was approved by the Ethics Committee of Guangdong Provincial People\u2019s Hospital (Approval No.: KY-Q-2021\u2013225-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing financial interests or personal relationships that could influence this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of interest statement"}},{"value":"No Generative AI was used in the preparation of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}